A learned stemness index guides a signature associated with breast-cancer outcomes
Source check: Source checked. Not independent scientific confirmation.
Finding: Researchers used a pre-existing one-class logistic-regression stemness index to derive a breast-cancer expression signature. Higher positive-signature expression was associated with shorter relapse-free survival and with recorded five-year metastasis in a separate cohort. These are observational associations, not proof of a causal stem-cell mechanism.
Technology: One-class logistic regression-derived stemness index
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- A previously trained one-class logistic-regression index supplies the stemness representation used to select the outcome-associated signature.
- Test and result
- Expression from 1,247 TCGA records was correlated with the learned index to define positive and negative signatures. Outcome analyses used 2,032 relapse-free-survival records and 1,979 METABRIC records.
- Limitation / still unknown
- Existing learned index reused; signatures and cohorts may overlap, and no new independent risk-model accuracy or causal effect is claimed. Experimental mechanisms and compound results elsewhere in the paper are outside this record.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11516096/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Exact primary front metadata and computational signature, bioinformatics and nonactionable clinical-association Results; operational experimental sections excluded..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.